Novo Nordisk shares fall as top investor drives board overhaul

Core Points - Shares in Novo Nordisk fell approximately 3% in early trading on Wednesday, continuing a downward trend from the previous day [1] - The decline in share price follows a proposal from the company's top investor for a comprehensive overhaul of the board [1] Company Summary - Novo Nordisk is known for its product Wegovy, which is a significant part of its portfolio [1] - The company's stock performance is currently under pressure due to governance concerns raised by its major investor [1]